Role of Anti-MICA Antibodies in Graft Survival of Renal Transplant Recipients of India

Journal of Immunology Research
Mohit ChowdhryVandana Sharma

Abstract

The MIC (MHC class I chain-related) genes are a group of nonclassical MHC genes, located in the MHC class 1 region of chromosome 6. The aim of the present study was to find the prevalence of MHC class 1 chain-related (MICA) alloantibodies in patients undergoing live-related donor renal transplantation and its role in short-term graft survival. The role of blood transfusion in the formation of these antibodies was also studied. Pretransplant samples of patients undergoing renal allograft transplantation were tested for anti-MICA antibodies. Association of various demographics, HLA-A + B + DRB1 mismatches, anti-HLA antibody screen, and anti-MICA antibodies was assessed using Pearson's chi-square test. Out of 646 serum samples, 94 (14.6%) were positive and 552 (85.4%) were negative for anti-MICA antibodies. Patients with anti-MICA antibody had a graft survival 89.3% as compared to 94.7% in patients without anti-MICA antibody (P < 0.05). The hazard ratio for all patients was 3.0701 (P < 0.05). Out of the 340 patients with no HLA antibodies, the presence of anti-MICA antibodies without any HLA antibodies (n = 43) was associated with poor outcome in the patients (hazard ratio of 2.768, P < 0.05). The presence of MICA antibodies with ...Continue Reading

References

Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·S BahramT Spies
May 4, 2005·Lancet·Gerhard Opelz, UNKNOWN Collaborative Transplant Study
Aug 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Kazuo MizutaniJarhow Lee
Sep 28, 2006·Human Immunology·Kazuo MizutaniMiyuki Ozawa
Jan 19, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·P I TerasakiR Castro
Sep 28, 2007·The New England Journal of Medicine·Yizhou ZouGerhard Opelz
Feb 26, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K SolezM Valente
Jul 14, 2012·Current Opinion in Organ Transplantation·Duska DragunRusan Catar
Sep 2, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Elena Sánchez-ZapardielEstela Paz-Artal

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SPSS
GraphPad Prism
GraphPad

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.